EyeConnect is a startup founded in 2018, specializing in optimizing processes in Ophthalmology through the integration of devices and specialized reporting services. Its slogan, "Otimização de processo na Oftalmologia através de integração de aparelhos e serviço de laudos especializados.," reflects its core mission.
The company aims to streamline ophthalmic processes by supporting practitioners to enhance productivity, increase revenue, and reduce costs. This is achieved through two primary methods: firstly, by integrating devices to automate the transfer of test results to their platform and subsequently into patient records, and secondly, by providing expert analysis and specialized reporting services through their team of specialists.
EyeConnect operates in the Health Care and Medical Devices industries, catering to the evolving needs of the healthcare sector by providing innovative solutions tailored to ophthalmic practices.
Despite not having publicly disclosed its headquarters, EyeConnect presents an intriguing opportunity for potential investors, with its unique value proposition in a rapidly growing sector.
As of now, the details of the last investment and the investors involved remain undisclosed. However, the potential for disruptive innovation in the healthcare technology space makes EyeConnect an interesting prospect for future investment opportunities. For more information, visit their website.
There is no investment information
No recent news or press coverage available for EyeConnect.